PMC:7264098 / 1369-1535 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T31","span":{"begin":69,"end":73},"obj":"DG_47"},{"id":"T32","span":{"begin":95,"end":103},"obj":"SP_7"},{"id":"T35718","span":{"begin":69,"end":73},"obj":"DG_47"},{"id":"T92850","span":{"begin":95,"end":103},"obj":"SP_7"}],"text":"currently 17 clinical trials evaluating the therapeutic potential of MSCs for the treatment of COVID-19, the majority of which are administered intravenously with onl"}

{"project":"LitCovid-PubTator","denotations":[{"id":"30","span":{"begin":95,"end":103},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"currently 17 clinical trials evaluating the therapeutic potential of MSCs for the treatment of COVID-19, the majority of which are administered intravenously with onl"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":95,"end":103},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"currently 17 clinical trials evaluating the therapeutic potential of MSCs for the treatment of COVID-19, the majority of which are administered intravenously with onl"}